Frontlight ResearchEarly access
Chronic kidney disease trials in United States
169 of 223 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 1/2Enrolling by invitationEnhancing the Natriuretic Peptide System in HFpEF
- Where
- Rochester
- Age
- 18 years and over
- People
- 60
- Run by
- Horng Chen
See details and how to joinNCT05279742 - No phaseNot yet taking people in United StatesThe Agenda-Setting for Kidney Disease Trial
- Where
- Lebanon
- Age
- 18 years and over
- People
- 108
- Run by
- Dartmouth-Hitchcock Medical Center
See details and how to joinNCT07024953 - No phaseTaking peopleThe Use of Risk Prediction to Identify Patients at Risk for Chronic Kidney Disease: Patient and Provider Interventions for Patients at High Risk for Chronic Kidney Disease
- Where
- Portland
- Age
- 18 years to 80 years
- People
- 1,500
- Run by
- Kaiser Permanente
See details and how to joinNCT07857200 - Phase 1Taking peopleA Study to Investigate Safety, Tolerability, PK, and PD of AZD4248 in Healthy Participants, Participants With CKD and Type 2 Diabetes, Assess Home Measurements of Creatinine in a Non-Interventional Cohort, and Assess the Effect of AZD4248 on the PK of Midazolam and Metformin in Healthy Participants
- Where
- Ann Arbor, Chicago, Glendale, Saint Paul, San Antonio
- Age
- 18 years to 75 years
- People
- 192
- Run by
- AstraZeneca
See details and how to joinNCT07024823 - Phase 2Not yet taking people in United StatesNicotinamide Riboside Supplementation in Chronic Kidney Disease
- Where
- San Diego
- Age
- 30 years and over
- People
- 30
- Run by
- University of California, San Diego
See details and how to joinNCT07693543 - Phase 3Not yet taking people in United StatesA Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes and Chronic Kidney Disease Treated With Once Daily Basal Insulin Alone or in Combination With Metformin, SGLT2i, or Both
- Where
- Bristol, Brooklyn, Chapel Hill, Chattanooga, Fleming Island, Hollywood, Houston, Katy, La Jolla, Lancaster, Las Vegas, Lincoln, Miami, Morehead City, Mt. Dora, Nashville, Ocoee, Orlando, San Antonio, San Dimas, Shavano Park, Spartanburg, Tamarac, Weston
- Age
- 18 years and over
- People
- 450 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07931547 · EU 2026-525471-13-00 - Phase 1Taking peopleSafety, Tolerability, Pharmacokinetics and Pharmacodynamics of OJR520 in Healthy Volunteers and Participants With Chronic Kidney Disease
- Where
- Miami
- Age
- 18 years to 65 years
- People
- 112 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07235059 - Phase 1Taking peopleStudy of ChoironeX GalKO Porcine Thymokidney Xenotransplantation in End-Stage Renal Disease
- Where
- New York
- Age
- 18 years to 70 years
- People
- 4
- Run by
- Xeno Holdings (US), LLC dba ChoironeX
See details and how to joinNCT07696962 - Phase 2Taking peopleTicagrelor for Inflammation and Cardiovascular Risk in Patients With Chronic Kidney Disease
- Where
- Little Rock
- Age
- 21 years to 75 years
- People
- 230
- Run by
- University of Arkansas
See details and how to joinNCT07911124 - No phaseNot yet taking people in United StatesAn Individuation Intervention to Reduce Socioeconomic Disparities in Chronic Kidney Disease Care
- Where
- Somerville
- Age
- 18 years and over
- People
- 216
- Run by
- Brigham and Women's Hospital
See details and how to joinNCT07921342 - No phaseNot yet taking people in United StatesTranscutaneous Auricular Vagal Neuromodulation Therapy (AVNT™) in Chronic Kidney Disease Autonomic Dysfunction
- Where
- New York
- Age
- 18 years and over
- People
- 30
- Run by
- NYU Langone Health
See details and how to joinNCT07927478 - No phaseTaking peopleEffects of Replacing High Protein Foods in People With Chronic Kidney Disease
- Where
- West Lafayette
- Age
- 40 years to 70 years
- People
- 15
- Run by
- Indiana University
See details and how to joinNCT07105670 - Phase 2Taking peopleA Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)
- Where
- Arlington, Arvada, Augusta, Bethlehem, Boca Raton, Bridgeville, Butler, Catonsville, Chattanooga, Chicago, Chula Vista, Cleveland, Coral Springs, Dallas, Garden Grove, Goose Creek, Hialeah, Houston, Lawrenceville, Livonia, Los Angeles, Louisville, Miami, New Bern, Orlando, Pontiac, Roanoke, San Dimas, Shelby, Valhalla, Worcester
- Age
- 18 years and over
- People
- 60
- Run by
- Akebia Therapeutics
See details and how to joinNCT07268638 - Phase 1Not yet taking people in United StatesA Study of Tersolisib (LY4064809) in Participants With Kidney Impairment Compared With Participants With Normal Kidney Function
- Where
- Altamonte Springs, Miami Lakes
- Age
- 18 years to 85 years
- People
- 32
- Run by
- Scorpion Therapeutics, a wholly owned subsidiary of Eli Lilly and Company
See details and how to joinNCT07924930 - Phase 3Taking peopleA Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
- Where
- Albany, Ann Arbor, Arlington, Arvada, Atlanta, Augusta, Austell, Austin, Bethesda, Beverly Hills, Boca Raton, Boston, Boynton Beach, Braintree, Bridgeville, Brunswick, Buffalo, Burlington, Butler, Canoga Park, Canton, Champaign, Charleston, Chattanooga, Cincinnati, Columbia, Columbus, Concord, Conyers, Dallas, Decatur, Denver, Detroit, East Point, East Providence, Eatontown, Edgewater, Evansville, Exton, Fairhope, Fort Lauderdale, Fremont, Fullerton, Garden City, Greenville, Hickory, Hollywood, Honolulu, Houston, Humble, Hutchinson, Idaho Falls, Indianapolis, Inglewood, Iowa City, Jacksonville, Jacksonville Beach, Kansas City, Kenner, Kinston, Knoxville, Lake City, Lakeland, Langhorne, Las Vegas, Lawrenceville, Lewisville, Los Alamitos, Los Angeles, Manassas, Maywood, Media, Melbourne, Metairie, Miami Lakes, Morehead City, Nashville, New Bedford, New Bern, New Britain, Newport News, New York, Norfolk, Ocoee, Orangeburg, Pasadena, Pearland, Port Charlotte, Port Orange, Providence, Raleigh, Richmond, Riverdale, Riverview, Rockford, Rocky Mount, Saint Joseph, San Antonio, San Diego, Sanford, San Francisco, Seattle, South Salt Lake, Springfield, Stanford, Statesville, St Louis, Sun City, Tarzana, Tucson, Washington D.C., West Des Moines, West Monroe, Wichita, Wilmington, Winston-Salem, Woodbridge, Worcester
- Age
- 18 years and over
- People
- 5,000 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06742723 · EU 2023-506460-14-00 - No phaseTaking peopleGuiding Optimal Blood Pressure Management in Peritoneal Dialysis Pilot Trial
- Where
- San Francisco
- Age
- 18 years and over
- People
- 10
- Run by
- University of California, San Francisco
See details and how to joinNCT07910773 - No phaseTaking peopleTranscutaneous Auricular Vagus Nerve Stimulation Device in CKD Population
- Where
- New York
- Age
- 18 years to 80 years
- People
- 20
- Run by
- NYU Langone Health
See details and how to joinNCT05981183 - Early phase 1Enrolling by invitationTruway Diagnostic Tools in Primary Care
- Where
- New York
- People
- 200
- Run by
- Truway Health, Inc.
See details and how to joinNCT07209527 - No phaseNot yet taking people in United StatesCommunity Health Worker Nutrition Self-Management Support for Cardio-Kidney-Metabolic Health
- Where
- Boynton Beach
- Age
- 18 years and over
- People
- 200
- Run by
- Florida International University
See details and how to joinNCT07918508 - No phaseTaking peoplePost Market Study for VasQ, an External Support Implant for Arteriovenous Fistula
- Where
- Atlanta, Boston, Columbia, Decatur, Greenwood, Houston, Las Vegas, Long Beach, Memphis, Nashville, New Orleans, Roanoke, Sarasota
- Age
- 18 years to 80 years
- People
- 300
- Run by
- Laminate Medical Technologies
See details and how to joinNCT06516653 - Phase 3Taking peopleA Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)
- Where
- Liège
- Age
- 50 years and over
- People
- 7,140 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07241390 · EU 2025-523123-22-00 - Phase 2Not yet taking people in United StatesREducing Systemic Inflammation With LOw-dose Colchicine to ImproVE Cardiovascular Calcification in Chronic Kidney Disease: A Pilot Randomized Open-Label Trial
- Where
- Dallas
- Age
- 30 years to 69 years
- People
- 60
- Run by
- University of Texas Southwestern Medical Center
See details and how to joinNCT07654231 - No phaseTaking peopleClinical Decision Support for SGLT2i After AKI in Type 2 Diabetes
- Where
- Minneapolis
- Age
- 30 years to 75 years
- People
- 250
- Run by
- University of Minnesota
See details and how to joinNCT07868666 - Phase 1Taking peopleA Study to Test the Safety of the Study Drug Fosmanogepix and How the Body Handles It in Adults With Severe Kidney Failure on Dialysis
- Where
- Orlando, Tampa
- Age
- 18 years to 80 years
- People
- 20
- Run by
- Basilea Pharmaceutica
See details and how to joinNCT07916181 - Phase 1/2Not yet taking people in United StatesBupropion for Fatigue in End-stage Kidney Disease Patients on Hemodialysis
- Where
- San Antonio
- Age
- 25 years to 74 years
- People
- 16
- Run by
- The University of Texas Health Science Center at San Antonio
See details and how to joinNCT06609343